Tag Archives: BrainStorm

Neurology Journal: BrainStorm Stem Cells May Help Huntington’s

February 1, 2012 | Comments are closed

BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI) announced that the prestigious Experimental Neurology Journal, published an article indicating that preclinical studies using cells that underwent treatment with Brainstorm’s NurOwn(TM) technology show promise in an animal model of Huntington’s disease. The article was published by leading scientists including Professor Eldad in serum...

BrainStorm Gets $1.1 M OCS Grant

November 6, 2011 | No comments

BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), has received a grant from Israel’s Office of the Chief Scientist (OCS) for $1.1 million (NIS 3.8 million) . BrainStorm is performing a Phase I/II human clinical trial in Israel with the company’s adult stem cell therapy in patients with ALS, often referred to...